Research aims to drag asthma management into the 21st century

May 2, 2017

A new study by University of Manchester researchers, published today - World Asthma Day - has probed the features that both patients and healthcare professionals want from an asthma management app.

Asthma treatment is currently managed by the use of written plans which help work out when to take their medication or seek advice. However, only a quarter of patients receive this and those that do often find it hard to stick to. To compensate, more than 200 have been developed, but these are often not informed by patient or professional needs.

The National Review of Asthma Deaths in 2014 concluded that two-thirds of asthma deaths were preventable.

The new study from The University of Manchester team incorporates focus group responses and written questionnaires from 183 patients and 63 professionals and has evaluated the features that they both find most useful to help inform future designs for apps.

One of the main functions that patients wanted from a mobile healthcare or 'mHealth' app was information on environmental conditions – such as pollen or pollution. They also wanted to be able to collect data that they could show their doctors. Professionals wanted apps to alert patients about when to receive medical help and to monitor adherence to their medication.

The latest study, published in the European Respiratory Journal, is part of a long-term, EU funded project called myAirCoach, to develop a useful and accessible mHealth device.

Lead researcher Dr Andrew Simpson, from The University of Manchester, said: "While smartphones have great potential for helping people manage their health, there has been such an explosion of different apps and devices that patients and professionals don't know what works best or if the design is up to the job.

"The idea of myAirCoach is to carefully work with these groups to find the best design and range of functions which help people manage their asthma."

With more than 300 million world-wide and 5.4 million in the UK affected by it, asthma is ideal for an mHealth approach. If a device or app can be created which is useful for both patients and healthcare professionals it has the potential to save lives, reduce hospital admissions and reduce the use of rescue medication.

The findings support the recommendations of a 2016 Asthma UK report, 'Connected asthma: how technology will transform care' which the research team contributed to, that called for asthma to be 'a focus and an exemplar for investment in technology-enabled self-management and clinician-led management in primary care'.

Dr Simpson concluded: "Although patients and we asked had differing priorities, there was overwhelming support for the creation of evidence-based mHealth to support management. The challenge is now to find the right design and technology to make this a reality."

Explore further: New MyAsthma app can help relieve the stress of asthma management

More information: 'Perspectives of patients and healthcare professionals on mHealth for asthma self-management.' Asthma.

myAirCoach: … t-myaircoach-project

Related Stories

New MyAsthma app can help relieve the stress of asthma management

April 12, 2017
A new and unique smartphone app to help people with asthma manage their condition has been developed by lung experts at the Nottingham Respiratory Research Unit and the pharmaceutical company GlaxoSmithKline (GSK).

Support people with asthma to manage their illness, researchers say

March 17, 2017
People with asthma should be given tailored support to help them manage their condition, experts say.

New roadmap provides blueprint to tackle burden of asthma

May 2, 2017
A new roadmap has been published identifying key priority areas that need to be addressed to tackle the burden of asthma.

Study links optimal asthma control with reduced health-care costs

November 10, 2016
In a study of 736 asthma patients in Singapore, good asthma control resulted in a saving of S$65 (US$48) per physician visit. Compared with an average cost of S$214 (US$158) per visit, this reduction represents a cost saving ...

Poor asthma control prevalent in the united states

February 28, 2012
(HealthDay) -- Many patients with asthma who do not use controller medications have persistent disease, and among those patients who do use controller medications, few have well-controlled disease, according to a study published ...

Certain red flags indicate an increased need for intensive care among patients with asthma

June 29, 2016
In patients admitted to the hospital for asthma, illicit drug use and low socioeconomic status were linked with an increased risk of requiring admission to the intensive care unit. Not adhering to asthma prevention medication ...

Recommended for you

Air pollution can increase asthma risk in adults, even at low levels

November 24, 2017
Living close to a busy road can be bad for your respiratory health if you are middle aged, new Australian research has found.

Evidence found of oral bacteria contributing to bowel disorders

October 20, 2017
(Medical Xpress)—An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders. In their paper published in the journal Science, the group describes ...

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

Asthma researchers test substance from coralberry leaves

September 14, 2017
The coralberry could offer new hope for asthmatics. Researchers at the University of Bonn have extracted an active pharmaceutical ingredient from its leaves to combat asthma, a widespread respiratory disease. In mice, it ...

Respiratory experts urge rethink of 'outdated' asthma categorisation

September 12, 2017
A group of respiratory medicine experts have called for an overhaul of how asthma and other airways diseases are categorised and treated.

New 'biologic' drug may help severe asthma

September 7, 2017
(HealthDay)—A "biologic" drug in development to treat severe asthma reduces the rate of serious attacks by about two-thirds compared to a placebo drug, according to preliminary research findings.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.